Print Page   |   Sign In   |   Join ISSX
ISSX Webinar Series
Share |

As an exclusive member benefit, ISSX invites members to attend the ISSX Webinar Series at no charge. Members can participate in regularly scheduled live webinars with an exciting range of speakers, as well as watch previous webinars on their own schedule. The ISSX Webinar Series is an engaging and innovative way to virtually hear from and interact with speakers from around the world on a range of topics related to the metabolism and disposition of xenobiotics.

View  previous webinars:

  • CYP3A Biomarkers in Humans for Drug Interaction Studies
    Tommy B. Andersson, Ph.D., AstraZeneca

  • The Use of BDDCS to Predict Drug Disposition in Drug Development of NMEs
    Leslie Z. Benet, Ph.D., University of California San Francisco

  • Biosynthesis of Drug Metabolites for Use in DMPK Experiments and Late-Stage Lead Diversification
    R. Scott Obach, Ph.D. and Greg S. Walker, Ph.D., Pfizer, Inc.

  • Drug Failures, Lessons for Future Drugs
    Dennis Smith, Ph.D.

  • Physiochemistry and ADMET
    Dennis Smith, Ph.D.

  • Quantitative Targeted Absolute Proteomics (QTAP): Methods and Applications for Studies of Proteins that Modulate Xenobiotic Disposition
    Phil Smith, Ph.D., University of North Carolina at Chapel Hill

  • The Use of “Extended Clearance Concept” and PBPK Modeling to Interpret Clinical Outcomes from In Vitro Metabolism and Transport Data; Focusing on the Transporters in the Liver
    Yuichi Sugiyama, Ph.D., Sugiyama Laboratory, RIKEN Innovation Center

 

Join ISSX to view the series recordings and make plans to attend future live webinar events!

Association Management Software Powered by YourMembership  ::  Legal